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A T  cell membrane antigen-recognition structure has recently been described 
ill several laboratories, including our own (1-6). This molecule is a heterodimer 
of approximately 80-90  Kd, composed of two disulfide-linked chains.  It fulfills 
many  of the  requirements  for the  T  cell  receptor for antigen,  such  as  major 
histocompatibility complex-restricted antigen recognition (2-4). This molecule 
has been studied on murine cells (1,  2, 4), human  T  cell clones (3), and human 
T  cell leukemia cells (5). 
The latter study, from this laboratory, described monoclonal antibodies reac- 
tive  with  idiotype-like determinants  on  a  human  T  cell  leukemia  (5).  Of two 
antibodies,  one  reacted  with  a  private  idiotype-like  determinant  and  another 
cross-reacted with  1-2%  of normal  T  cells by immunofluorescence. Both anti- 
bodies immunoprecipitated the same ~80 Kd disulfide-linked heterodimer from 
the membrane-iodinated leukemic cells, and this molecule comodulated with the 
T3  molecule. Thus,  strong  indirect evidence suggested  that  these  monoclonal 
antibodies were recognizing a  T  cell antigen receptor. The presence of private 
idiotypic determinants  and  shared  determinants  on  this  molecule suggested  a 
general structure similar to that of immunoglobulin molecules (7). 
This  paper  compares  two  T  cell  antiidiotypic  antibodies  each  specifically 
reactive with their respective leukemia T  cell clone.  Immunoprecipitation  with 
these  antibodies  revealed  major  differences between  the  two  idiotype-bearing 
heterodimer molecules. In addition, proliferation studies in response to Sepha- 
rose-linked antiidiotypic antibody revealed marked differences between the two 
T  cell leukemias. 
Materials and  Methods 
Cell Preparations.  Cells  derived from the peripheral blood of a  patient with Sezary 
syndrome, patient  SU,  and  another patient  with  T  celt  chronic lymphocytic leukemia 
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(CLL), ~  patient FF, were obtained by Ficoll-Hypaque density centrifugation and used for 
immunizations of mice to develop monoclonal antibodies.  Other cell preparations used 
were obtained from blood or teased tissues by similar means.  Endothelial  cell  cultures 
were  obtained  from  Dr.  E.  A. Jaffe (8).  The  cell  lines  used  for immunofluorescence 
included the following T  cell lines:  MOLT 4, KE 37, HPB-ALL, 1301, CEM-T, Jurkat, 
SKW 3, GM 3671, GM 3639, GM 4155, HUT 102, HUT 78 and three different human 
T-T cell hybridomas. The B cell lines included: GM 1899, RPMI 8866 P, ARH-77, CESS, 
JOSH 7, U 266, two Epstein-Barr virus (EBV)-derived cell lines from normal donors and 
an EBV-derived cell line from patient FF.  Mitogen-activated T  cells were obtained after 
stimulation  with  phytohemagglutinin  (PHA,  Gibco  Laboratories,  Grand  Island,  NY), 
pokeweed mitogen (PWM, Gibco), concanavalin A (Con A, Sigma Chemical Co., St. Louis, 
MO), phorbol acetate (TPA, Consolidated Midland Corp.), and staphylococcus protein A 
(SPA, Pansorbin brand, Calbiochem-Behring Corp.,  La Jolla, CA).  Mitogen-activated B 
cells were obtained using TPA,  SPA,  and  tuberculin-purified protein  derivative (PPD, 
Connaught Lab Ltd.). 
T Cell Antiidiotypic Monoclonal Antibodies.  The monoclonal antibodies S 160 and $511 
have been described (5) and recognize the idiotype-bearing molecule Tid SU. S 160 reacts 
with a private idiotypic determinant and $511  reacts with a shared determinant, since it 
stains  1-2%  of normal  T  cells.  Cells  from patient  FF  were  used  to  generate  murine 
monoclonal antibodies as described elsewhere (9). Hybridomas of interest were cloned on 
soft agar.  Culture  supernatants  or  appropriate  dilutions  of murine  ascites  containing 
monoclonal antibodies in saturating dosages were used for indirect immunofluorescence 
and immunoprecipitations. A fluorescein-conjugated F(ab'),2 goat anti-mouse Ig antiserum 
(Tago Inc., Burlingame, CA) was used for immunofluorescence, which was evaluated with 
a cytofluorograph (30-H, Ortho Diagnostic Systems Inc., Westwood, MA); results were 
checked visually on a fluorescent microscope. For modulation experiments and prolifer- 
ation experiments the monoclonal antibodies $51 I, S160, and FFA26 were purified by 
45% ammonium sulfate precipitation and gradient DEAE ion exchange chromatography 
and then coupled to CnBr-activated Sepharose 4B (Pharmacia).  1 g of Sepharose beads 
bound 9.8 mg S5II, 5.7 mg S160 and 9.0 mg FFA26 antibody. 
Modulation.  The methods used have been described (I0). Briefly, cells were cultured 
in the presence of saturating concentrations of monoclonal antibodies in regular culture 
medium  (RPMI  1640,  10%  fetal  calf serum,  1%  glutamine,  1%  penicillin,  and  1% 
streptomycin) for  -24  h,  washed  three  times,  and  stained  by direct  (Leu-4a,  Leu-3a 
antibodies; Becton, Dickinson & Co.) and indirect immunofluorescence (all other antibod- 
ies). Modulation also was induced by monoclonal antibodies bound to Sepharose. 
Stimulation  of Leukemic  T  Cells  by  Antiidiotypic  Antibodies.  Leukemic  T  cells  were 
cultured at  106 cel]s/ml in Linbro flat-bottom 96-well plates for various durations in the 
presence of different concentrations of Sepharose-coupled antiidiotypic antibodies with 
or without  purified  human  IL-2 (Electro-Nucleonics,  Inc.) and  ultra-pure human  IL-1 
(Genzyme). Proliferation of cells was assayed for by [3H]thymidine uptake. Binding of the 
cells to  their  respective antiidiotypic antibodies coupled  to Sepharose  was  determined 
visually with an inverted microscope. 
Immunoprecipitation  and  Gel  Electrophoresis.  Cell  membranes  were  iodinated  using 
lactoperoxidase (Sigma) at  10 #g/5  x  107 cells and glucose oxidase (Calbiochem) at 0.1 
U/5  x  107 cells in  the presence of glucose and  J25I Na iodide (New  England  Nuclear, 
Boston, MA). lmmunoprecipitations and sodium dodecyl sulfate-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) were performed as described elsewhere (1,5). Two-dimensional 
gel electrophoresis was performed according to O'Farrel (11), with some modifications. 
First-dimensional resolution was carried out on an isoelectric focusing slab gel using pH 
3.5-10 ampholines (LKB Instruments, Gaithersburg, MD). The slabs were then cut into 
strips for the second dimension resolution by SDS-PAGE. The isoelectric focusing strip 
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was placed on top of an  11.5% acrylamide  gel.  Molecular weight standards were run on 
each gel. Gels were then stained, destained, dried on filter paper, and autoradiographed 
on Kodak X-Omat R  film. 
Results 
Production of an Anti-T Cell Idiotype Monoclonal Antibody.  Human T  lympho- 
cytes from a  patient  with  T  cell  CLL  (FF)  were used to  immunize mice and 
generate monoclonal antibodies specific for this malignant clone ofT cells. These 
cells had the following membrane phenotype revealed by indirect immunofluo- 
rescence: TI+, T3+, T4+, T11+, T6-, T9-, T10-,  Ia-, Leu7-, Tac+. Cells 
from a  Sezary cell leukemia (SU), also examined in this study, differed slightly 
in  membrane phenotype:  TI+,  T3+,  T4+,  Tll+,  T6-,  T9-,  T10-,  Ia-, 
Leu7-, Tac-. 
From 90 monoclonal antibodies, one revealed total specificity for the FF cells 
used for immunization. This antibody (FFA26) failed to react with all other cell 
types tested (Table I),  including a  number of T  cell leukemias, normal T  cells, 
thymocytes, T  cell lines, and mitogen-activated T  cells.  Other tested cell types 
are listed in Table 1 and include normal, activated, and malignant B cells, and 
several different sources of lymphohematopoietic cell types and cell lines.  An 
EBV-derived B lymphoblastoid cell line from the patient FF also failed to stain 
TABLE  I 
Reactivities of the Antibody FFA26 with Various Celt Types 
Cell type (No. of samples)  % ceils staining 
FF, T  cell CLL  90 
FF, EBV-derived B cell line  0 
Other T  cell leukemias (9)  0 
B cell leukemias (4)  0 
Normal T  cells (10) 
Normal non-T mononuclear cells (7) 
Normal activated T  cells (3)* 
Normal activated B cells (1)* 
0 
0 
<2 
<2 
T  cell lines (15)*  <2 
B cell lines (8)*  <2 
Spleen (2)  0 
Thymus (1)  0 
Bone marrow (2)  0 
Cord mononuclear cells (1)  0 
Granulocytes (1)  0 
Platelets (2)  0 
Cultured endothelial cells (1)  0 
Cell lines (HL60,  U937, K562)*  <2 
* Because of the larger background fluorescence observed with the neg- 
ative control antibody in these cell populations, small numbers of weakly 
stained cells cannot be assessed and negative results are therefore ex- 
pressed  as <2%.  Negative control antibodies were  the same as those 
mentioned in Table If. POSNETT  ET  AL.  497 
with  FFA26,  thus eliminating  the  possibility that  this antibody  reacted  with  a 
rare allotypic determinant of an HLA molecule, which would be expected to be 
present on both T  and B cells. The cell line HUT 102, which harbors human T 
cell  leukemia  virus  and  its  associated  membrane  antigens,  did  not  react  with 
FFA26. The other T  cell leukemias included three cases of Sezary syndrome, a 
case  of mycosis fungoides,  one  adult  T  cell  leukemia,  and  four  T  cell  acute 
lymphoblastic leukemias. All but two of these T  cell leukemias had a T3+, T4+, 
T8-  membrane  phenotype.  The  other  two,  however,  expressed a  suppressor 
phenotype: T3+, T4-,  T8+. Thus,  the monoclonal antibody FFA26 is specific 
for the malignant  clone of cells from patient FF. This specificity is idiotype-like 
and resembles the specificity of previously described antibodies (1, 6), including 
those generated against SU cells (5). 
Comodulation  of T3 Antigen with the T Cell Idiotypic  Antigen.  Previous studies 
have  demonstrated  a  close  association  of the  T3  molecule  with  the  T  cell 
idiotype-bearing structure on T  cell clones (3) and on human  T  leukemia cells 
(5), demonstrated by comodulation experiments.  In a similar manner the T  cell 
idiotype-bearing molecule of FF cells (Tid FF) and the T3 molecule comodulate 
(Table II).  Modulation  could be induced by both soluble and Sepharose-linked 
FFA26  antibody.  Comodulation  was  specific  for  the  antigens  recognized  by 
FFA26 and the Leu 4a antibody which detects the T3 molecule. Other surface 
antigens on FF cells did not comodulate, including T4 and T 11 (data not shown) 
and two other membrane antigens present on the FF cells (Table II). In addition, 
reappearance of T3 and Tid FF antigens was demonstrated 24 h after continued 
culture of FF cells in  the absence of the  modulating  antibody,  thus indicating 
that  FF  cells  in  culture  are  able  to  re-express  the  Tid  FF  molecule.  These 
modulation properties of FF cells are the same as for SU cells with their respective 
antiidiotypic antibodies (5). Thus, the antiidiotypic antibodies reacting with their 
respective T cell leukemias appeared to be very similar. However, further studies 
mentioned  below,  comparing  these  two  systems side  by side,  revealed  major 
differences. 
Stimulation  of Leukemic Cells by Sepharose-linked  Antiidiotypic  Antibody.  In pro- 
liferation studies the two leukemic cell types, FF and SU, behaved quite differ- 
ently.  FF  cells  that  express  the  Tac  antigen  proliferated  in  response  to  IL-2. 
TABLE  II 
Modulation of Membrane Antigens on FF Cells 
Antibody used to in-  Percentage of cells staining with 
duce modulation  Leu 4a  FFA26  FFB2*  FFA85*  Control  ~ 
Leu 4a  3  11  98  92  6 
FFA26-seph 0.1%  8  11  99  99  4 
FFA26-seph 0.001%  90  96  98  93  1 
Control sepb 0.1%  96  93  96  89  1 
* FFB2 and FFA85 are murine monoclonal antibodies generated against 
FF cells and reactive with antigens on T  cells as well as other cell types. 
Control antibodies were murine monoclonal antibodies, specific for an 
IgM kappa private idiotypic determinant and for the hapten dinitrophe- 
nol. Neither of the negative control antibodies has reacted with any cell 
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However, the  Tac-negative  SU cells did  not  incorporate  [3H]thymidine  in  the 
presence of IL-2, and a response of these cells could not be induced by further 
addition of IL-1 to the culture medium or by the addition of $511-seph antibody 
with or without IL-I and IL-2. The failure of $511-seph to activate SU cells was 
not due to loss of antibody activity, since these Sepharose beads clearly bound to 
the SU leukemia cells in a specific manner  (Fig.  1). Likewise FFA26-sepb beads 
bound specifically to the FF leukemia cells. Fig.  1 illustrates  clusters of FF cells 
typically seen  in  association  with  FFA26-seph  beads, indicating  that  these cells 
were proliferating  in  response  to stimulation  by FFA26-seph.  This was clearly 
demonstrated in a dose response titration of FFA26-seph, which shows a marked 
increase in [3H]thymidine incorporation at optimal concentration of FFA26-seph 
over the baseline incorporation  due to IL-2 alone (Fig.  2).  This stimulation  was 
specifically induced by FFA26-seph and not by $51 l-seph.  In addition,  further 
experiments,  using  other  Sepharose-linked  antibodies  that  bound  to  FF  cells 
(FFB2 and  FFA85, see Table II), demonstrated absence of stimulation  by these 
antibodies in contrast to FFA26-seph. SU cells failed to respond to IL-2, $511- 
seph,  or  FFA26-seph  (Fig.  2).  The  possibility  that  $511-seph  was  toxic  for 
lymphocytes  was  ruled  out,  since  $511-seph  did  not  prevent  FF  cells  from 
proliferating in response to IL-2 (Fig. 2) and did not affect cell viability (Fig.  1), 
and >88%  of SU cells excluded  trypan  blue during  the  2-d culture period.  In 
addition,  other experiments showed that  $51 l-seph could support and increase 
FIGURE  1.  Photomtcrographs of leukemic T  cells in culture with Sepharose-linked antiidi- 
otypic antibodies. SU cells are shown in panels A and B, FF cells in C and D. FFA26-seph was 
added to the cultures in A and C, while S511-seph was added in B and D. The two different 
leukemic cell types were bound by the appropriate antiidiotypic antibody in B and C, but not 
by the unmatched antibody in A and D. In addition, FF cells are clustered in panel C, suggesting 
that they are proliferating. POSNETT  ET  AL.  499 
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FXC;URE 2.  Proliferation of leukemic cells was measured by [3H]thymidine  incorporation on 
day 2, expressed in counts per minute (cpm). Each point represents a mean of three values. 
Standard deviations ranged up to +/- 2,009 cprn. Culture conditions and cell types are: FF 
cells, 10%  IL-2, increasing concentrations  of FFA26-seph (O  O);  FF cells, 10%  IL-2, 
increasing concentrations of $511-seph (H);  SU cells, 10% IL-2, increasing concentra- 
tions of $511-seph (O-----O); SU cells, 10%  IL-2, increasing concentration  of FFA26-seph 
(@-----@); FF cells, 10% IL-2 (  ); SU cells, 10% IL-2 (- - -). Optimal proliferation of FF 
cells was observed with 0.3% FFA26-seph. Control cultures without IL,2 or Sepharose beads 
incorporated negligible amounts of [3H]thymidine: 633 cpm (FF cells) and 218 cpm (SU cells). 
the proliferation of a $511-positive, IL-2-dependent T  cell line, derived from a 
normal donor. This cell line is currently under further investigation (Bigler, R. 
D.,  D.  N.  Posnett,  and  N.  Chiorazzi,  manuscript  in  preparation),  because  it 
represents the small population of normal T  cells identified by the $51 1 antibody 
(5). 
FFA26-seph  is capable of stimulating  FF cells to proliferate in the absence of 
exogenously added IL-2 (Fig.  3). This response is amplified by addition of IL-2 
to the culture medium. The maximal point of proliferation occurs after 2-3 d 
of culture. We questioned whether FF cells produce IL-2 in response to FFA26- 
seph.  Such  an  autocrine  secretion  of  IL-2  could  result  in  the  proliferation 
observed with FFA26-seph  by interaction of IL-2 with  IL-2 receptors constitu- 
tively present on these cells. Supernatants were thus obtained from proliferating 
FF cells on day 2 of culture with optimal concentrations of FFA26-seph or PHA. 
At that point, mean [3H]thymidine incorporation was  11,760  +/-  238 cpm for 
FFA26-seph-stimulated  cells,  27,112  +/-  1133  cpm for PHA-stimulated cells, 
and  744  +/-  130  cpm  for  the  culture  medium  control.  Using  a  previously 
described assay for IL-2 (12), these supernatants were all found to contain <0.05 
U  IL-2  activity. This suggested  that  FF  cells are  incapable  of producing  IL-2 
under the conditions tested. However, these results do not exclude the possibility 500  T  CELL  ANTIID1OTYPIC  ANTIBODIES 
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FIGURE  3.  Proliferation kinetics of FE cells stimulated by FFA26-seph,  measured by [SH]- 
thymidine incorporation (cpm), with no IL-2 added to the medium (O-------O), and with 10% 
I L-2 added to the medium (O  O). Each point represents a mean of three values. Standard 
deviations ranged up to +/-  4,628 cpm. Control cultures without added FFA26-seph did not 
proliferate: <1,000 cpm. 
that small amounts of IL-2 may have been produced and immediately consumed 
by the FF cells, which express membrane IL-2 receptors. 
Cells  of  Two  Different  T  Cell  Leukemias  Bear  Different  Tid  Molecules.  Im- 
munoprecipitation  after cell membrane  iodination  and NP40 cell lysis revealed 
clear differences and some similarities  between the two idiotype-bearing T  cell 
molecules  (Tid).  Immunoprecipitates  of both  molecules  and  their  respective 
antiidiotypic antibodies are shown on a  5-20% acrylamide gradient gel (Fig. 4). 
Unreduced TidFF was clearly larger than the TidSU molecule. The TidFF band 
was observed at a position of 90-95 Kd, while the TidSU band was at a position 
of ~78  Kd.  In the reduced state both molecules were composed of two distinct 
chains: (a) a heavily iodinated chain and (b) a lightly iodinated chain.  The latter 
type of chain from both molecules co-migrated at 43 Kd, but the heavily labeled 
chains were quite different in relative mobility (lanes 3 and 4, Fig. 4). The heavily 
labeled Tid FF band has a position of 49 Kd, while the heavily labeled Tid SU 
hand  has  a  position  of 38  Kd.  Despite  these  differences,  both  molecules are 
similar, in that both were disulfide-linked heterodimers, with molecular weights 
similar to those reported for clonotypic molecules in mouse and man (1-6). 
Characterization  of these  molecules  by two-dimensional  gel  electrophoresis 
demonstrated further differences. The co-migrating 43 Kd chains from the two 
molecules appeared to be different (Fig. 5). Both chains of the SU molecule had 
slightly acidic and overlapping pI values. In contrast, the FF molecule contained 
an acidic chain  (49 Kd) and a  neutral  chain  (43  Kd).  In  both molecules micro- POSNETT  ET  AL.  501 
FIGURE 4.  SDS-PAGE analysis of membrane iodinated leukemic cells on a 5-20% acrylam- 
ide gradient gel. Conditions are unreduced (lanes 1, 2) and reduced with 0.1  M DTT (lanes 
3, 4). Iodinated FF cell lysates were immunoprecipitated with FFA26 (lanes 1, 3) and iodinated 
SU cell lysates were immunoprecipitated with $511 (lanes 2, 4). The positions of cold molecular 
weight markers are indicated.  These were ovalbumin (43  Kd), bovine albumin (69  Kd), and 
human  transferrin  (79 Kd). The faintly visible lower bands  in lanes  1-3 were not consistent 
findings on other gels and were interpreted as nonspecific. 
heterogeneity of both chains was observed, suggesting that these molecules are 
glycosylated proteins.  However,  the  observed  differences in  molecular  weight 
between TidSU and TidFF are unlikely to be solely due to glycosylation differ- 
ences. 
Discussion 
In order to compare the putative receptor for antigen on two different T  cell 
leukemias, monoclonal antibodies with idiotype-like specificity were produced. 
Such antibodies were obtained with each of the two different T  cell leukemias 
and demonstrated (a)  idiotypic specificity, (b)  comodulation of the T3  antigen 
and the idiotype-bearing molecule, and (c) immunoprecipitation of a  disulfide- 
linked heterodimer from the respective leukemic cells. These results are remark- 
ably similar to recently reported data on the putative T  cell receptor for antigen 
(1-6). 
FFA26 is an antibody that recognized a  private idiotypic determinant of FF 
leukemia cells. In addition, this antibody selectively induced FF cells to prolifer- 
ate, quite as antigen may induce T  cells to proliferate by reacting with the major 
histocompatibility-restricted antigen receptor. Antiidiotypic antibodies may thus 
mimic antigen by inducing specific proliferation of the idiotype-bearing T  ceils. 
Both  proliferation  and  IL-2  secretion  have  been  observed  with  T  cell  clones 
stimulated by Sepharose-linked anticlonotypic antibodies (14,  15).  However,  it 502  T  CELL  ANTIIDIOTYPIC ANTIBODIES 
FIGURE 5.  Two-dimensional gel analysis of reduced TidFF (upper panel) and TidSU (lower 
panel). The isoelectric point of the upper band of TidFF is acidic, while that of the lower band 
is neutral. Both bands of TidSU are slightly acidic. The co-migrating 43 Kd chains of TidFF 
and TidSU are different when analyzed by isoelectric focusing. All chains consist of multiple 
spots, indicating that they are glycosylated~ 
t'emains  unclear  to  what  extent  the  observed proliferation  is  due  to autocrine 
production of IL-2 and  whether this is  the primary mechanism  by which  these 
T  cell clones are induced to proliferate. 
]'he effects of antiidiotypic antibodies on  two human  T  cell  leukemias  were 
compared. While FF cells could easily be induced to proliferate by FFA26-seph, 
SU cells consistently failed to respond to $511-seph, in spite of visible binding of 
the SU cells to the antibody-coated beads.  This difference was also reflected by 
a  general responsiveness of FF cells to IL-2 and various mitogens and a  general 
unresponsiveness of SU cells to IL-2 and mitogens.  A  possible interpretation of 
the difference between SU and FF cells is that they represent leukemic transfor- 
mation of T  cells at different stages of differentiation. Morphologically, SU and 
FF cells differ significantly. SU cells are typical Sezary cells with multiple nuclear 
lobulations and it is likely that they home to skin, since the patient demonstrated 
leukemic infiltration of the epidermis.  FF cells in contrast are small lymphocytes 
typical of CI.L residing primarily in  the peripheral blood, spleen, lymph nodes, 
and  bone  marrow  of the patient.  A  possible  interpretation  is  that  SU  cells are POSNETT  ET  AL.  503 
end-stage cells in T  cell differentiation, similar to plasma cells in B cell differen- 
tiation.  The inability of SU cells to respond to $511-seph can also be compared 
to leukemic B lymphocytes, such as CLL cells, that frequently fail to respond to 
cross-linking of their  membrane  immunoglobulin,  in contrast to normal  B cells 
(12). 
The mechanism of proliferation induction of FF cells by FFA26-seph does not 
appear to primarily involve IL-2 secretion. FF cell culture supernatants contained 
no  measurable  IL-2,  when  stimulated  under  optimal  conditions.  In  addition, 
FFA26-seph  could  induce  increased  proliferation,  in  spite  of the  presence  of 
excess IL-2 (Fig. 2). These results indicate that cross-linking of the T  cell receptor 
for antigen  may cause T  cell proliferation  by mechanisms other than  induction 
of IL-2 secretion. The results do not exclude the possibility that small amounts 
of IL-2  may have  been  produced and  immediately consumed by the  FF cells, 
which express membrane IL-2 receptors. However, the recent report by Arya et 
al.  (16)  of failure  to  find  IL-2  mRNA  in  virus-transformed  T  lymphocytes, 
supports the notion that  IL-2-independent  mechanisms may operate in normal 
or malignant  T  cell proliferation.  In addition,  the response of FF cells to cross- 
linking of their  putative membrane antigen  receptor by the FFA26-seph beads 
is quite like the response of human  B cells to cross-linking of membrane immu- 
noglobulin, the B cell antigen receptor, by anti-immunoglobulins.  In both systems 
proliferation  peaks after 2  d  of culture and can  be achieved in  the absence of 
growth  factors (BCGF,  IL-2).  In  the  human  B cell system this  requires a  high 
concentration  of soluble anti-immunoglobulin  (12) or insolubilized  anti-immu- 
noglobulin (17). FF cells also proliferated in response to insolubilized antiidiotypic 
antibody, but failed to show such a  response with soluble antibody in the form 
of hybridoma supernatant (data not shown). 
The antiidiotypic antibodies revealed a further major difference between the 
two leukemic cell types and their respective Tid molecules. Immunoprecipitation 
studies showed a relatively large difference in molecular weight between the two 
Tid molecules. This was possibly due to a difference in one of the two disulfide- 
linked  chains.  Thus,  the  upper  band  of TidFF and  the  lower band  of TidSU 
were both  heavily  labeled by iodination  in  contrast  to  the  two lightly  labeled 
bands,  both  migrating  at 43  Kd.  The  heavily labeled bands of TidFF (49  Kd) 
and TidSU (38 Kd) are sufficiently different in molecular weight to explain the 
size difference of the  two unreduced  molecules.  The  alpha  and  beta chain  as 
described  previously  (1-6,  14,  18)  migrate  as  the  upper  and  lower  bands, 
respectively on SDS-PAGE analysis and are usually acidic (alpha) and basic (beta) 
on two-dimensional analysis. It is possible that, in the case of TidSU, the position 
of these chains is inverted (Fig. 4). 
A possible explanation for the differences observed between TidSU and TidFF 
is that they belong to different classes of T  cell receptors for antigen.  Classes of 
T  cell receptors for antigen  are expected, based upon analogy with the immu- 
noglobulins.  They have, however, not yet been clearly demonstrated  in mouse 
or man. Constant region antigenic determinants will be useful for defining classes 
of the T  cell receptor for antigen. In this respect, it is of interest that the antibody 
$511, which cross-reacts with a small subpopulation of normal T  cells by immu- 
nofluorescence  and  immunoprecipitates  a  disulfide-linked  heterodimer  from 504  T  CELl.  ANTIIDIOTYP1C  ANTIBODIES 
these normal  T  cells,  does not stain  FF cells or immunoprecipitate  a  molecule 
from  FF  cells  (Bigler,  R.  D.,  D.  N.  Posnett,  and  N.  Chiorazzi,  manuscript  in 
preparation).  These results lend further  support to the contention  that  TidSU 
and  TidFF  represent  two different  groups  of the  presumptive  T  cell  antigen 
receptor. 
Recently, the cDNA sequence of a  rearranged  T  cell gene encoding for a  T 
cell-specific protein chain  has been described in mouse and man (19-21). This 
molecule has variable, joining, and constant regions and an estimated molecular 
weight of 35,000. The features of cell specificity, variable and constant portions 
of the molecule, and the molecular weight of the single chain, are all similar to 
those of the TidFF and TidSU molecules, further supporting the suggestion that 
they represent the T  cell receptor for antigen. 
Summary 
Two different human T  cell leukemias were compared, using antiidiotype-like 
murine monocJonal antibodies. In each case these antibodies immunoprecipitated 
disulfide-linked heterodimer molecules from their respective leukemic ceils. On 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis 
of the  two idiotype-bearing  molecules a  major  difference in  molecular  weight 
was observed,  which  could be attributed  to a  similar  difference in  size  of the 
heavily iodinated  chain  of either  heterodimer.  The  lightly  iodinated  chains  of 
both molecules co-migrated at 43 Kd, but appeared to have different isoelectric 
points on  two-dimensional  gel analysis.  The possibility that  these two different 
heterodimers correspond to different classes of the putative T  cell receptor for 
antigen  is discussed. 
Assays of proliferation  of the  leukemic  cells  using  Sepharose-bound  antiidi- 
otype-like  monocional  antibody  showed  that  one  of  the  leukemic  cell  types 
proliferated  readily in response to its antiidiotypic antibody.  This proliferation 
was not associated with  measurable  production  of IL-2  and  appeared  to be a 
direct  effect  of  the  antiidiotypic  antibody,  which  may  mimic  antigen  in  its 
interaction  with  the T  cell receptor for antigen.  The  other leukemic  cell type 
did  not  respond  to  Sepharose-bound  antiidiotypic  antibody and  was generally 
unresponsive to lymphokines and mitogens.  It is possible that the two leukemic 
cell types represent different stages of T  cell differentiation. 
Rosanne Wisniewolski, Robert Folkl, and David Solomon  provided technical  assistance. 
Pamela Bolton prepared the manuscript. 
Received for publication  2 April 1984. 
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